Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.6000
+0.0599 (11.09%)
At close: Apr 2, 2026, 4:00 PM EDT
0.5999
-0.0001 (-0.02%)
After-hours: Apr 2, 2026, 7:40 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $24.51 million as of April 2, 2026. Its market cap has decreased by -38.46% in one year.
Market Cap
24.51M
Enterprise Value
-34.67M
1-Year Change
-38.46%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $24.51M, a decrease of -95.77%. That is a compound annual growth rate of -47.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 24.51M | -14.26% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 25.92M |
| Lexaria Bioscience | 25.88M |
| IGC Pharma | 25.40M |
| Daré Bioscience | 25.33M |
| Plus Therapeutics | 24.43M |
| Boundless Bio | 24.20M |
| Neuphoria Therapeutics | 23.77M |
| Quantum BioPharma | 23.46M |